Clinical Trials Browser

Carcinoma, Renal Cell, Neovascularization, Pathologic

NCT05741671 2023-02-23

MYOVASC

Unknown

760 enrolled

Leiomyoma, Neovascularization, Pathologic

NCT04346472 2020-04-16

SPECIFY

Completed

200 enrolled

CNS

Glioma, Neovascularization, Pathologic, Supratentorial Neoplasms, Disease Progression

NCT01367288 2019-05-28

NEOZOL

Phase 2 Completed

53 enrolled

Breast

Breast Neoplasms, Neovascularization, Pathologic

NCT02759796 2017-04-24

Fluorescence Angiography in the Assessment of DIEP Flap Perfusion

Phase NA Completed

60 enrolled

Breast

Breast Neoplasms, Fat Necrosis, Neovascularization, Pathologic

NCT01679223 2015-01-09

Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12

Unknown

60 enrolled

Breast

Breast Neoplasms, Neovascularization, Pathologic

NCT00248820 2007-11-22

Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses

Phase NA Unknown

100 enrolled

Gynecologic

Neovascularization, Pathologic, Ovarian Neoplasms

NCT00245869 2007-02-21

Ultrasound and Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response

Phase NA Completed

30 enrolled

Breast

Breast Neoplasms, Neovascularization, Pathologic

NCT00162669 2006-09-08

Bevacizumab in Advanced Hepatocellular Carcinoma

Phase 2 Unknown

50 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Neovascularization, Pathologic

Clinical Trials

RUBIKID

MYOVASC

SPECIFY

NEOZOL

Fluorescence Angiography in the Assessment of DIEP Flap Perfusion

Incorporation of AlloMaxTM in Breast Reconstruction Ver8-15-12

Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses

Ultrasound and Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response

Bevacizumab in Advanced Hepatocellular Carcinoma